Alliancebernstein L.P. Incyte Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Incyte Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 246,198 shares of INCY stock, worth $17.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

246,198

Previous 314,787 21.79%

Holding current value

$17.7 Million

Previous $19.1 Million 14.72%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $3.93 Million - $4.71 Million	-68,589 Reduced 21.79%	246,198 $16.3 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $1.12 Million - $1.4 Million	21,956 Added 7.5%	314,787 $19.1 Million
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $767,213 - $903,426	-13,567 Reduced 4.43%	292,831 $16.7 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $871,697 - $1.07 Million	16,712 Added 5.77%	306,398 $19.2 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $1.42 Million - $1.62 Million	-24,615 Reduced 7.83%	289,686 $16.7 Million
Q2 2023 Aug 15, 2023	BUY	$60.95 - $75.51 $4.49 Million - $5.56 Million	73,601 Added 30.58%	314,301 $19.6 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $4.95 Million - $6.06 Million	-70,485 Reduced 22.65%	240,700 $17.4 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $4.87 Million - $6.1 Million	72,480 Added 30.36%	311,185 $25 Million
Q3 2022 Nov 15, 2022	SELL	$66.18 - $82.86 $12.1 Million - $15.1 Million	-182,472 Reduced 43.32%	238,705 $15.9 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $12 Million - $15 Million	180,875 Added 75.27%	421,177 $32 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $5.66 Million - $6.84 Million	-85,799 Reduced 26.31%	240,302 $19.1 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $323,097 - $378,035	-5,101 Reduced 1.54%	326,101 $23.9 Million
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $5.31 Million - $6.5 Million	77,369 Added 30.48%	331,202 $22.8 Million
Q2 2021 Jul 30, 2021	SELL	$79.87 - $87.53 $1.45 Million - $1.59 Million	-18,123 Reduced 6.66%	253,833 $21.4 Million
Q1 2021 May 06, 2021	BUY	$76.02 - $100.5 $420,618 - $556,066	5,533 Added 2.08%	271,956 $22.1 Million
Q4 2020 Feb 08, 2021	SELL	$80.74 - $97.7 $19.7 Million - $23.8 Million	-244,031 Reduced 47.81%	266,423 $23.2 Million
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $1.93 Million - $2.48 Million	22,630 Added 4.64%	510,454 $45.8 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $5.32 Million - $7.81 Million	71,687 Added 17.23%	487,824 $50.7 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $31.9 Million - $43.4 Million	-504,355 Reduced 54.79%	416,137 $30.5 Million
Q4 2019 Feb 18, 2020	SELL	$73.04 - $95.72 $6.11 Million - $8.01 Million	-83,700 Reduced 8.34%	920,492 $80.4 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $3.03 Million - $3.6 Million	41,617 Added 4.32%	1,004,192 $74.5 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $8.34 Million - $10.1 Million	113,392 Added 13.35%	962,575 $81.8 Million
Q1 2019 May 14, 2019	SELL	$63.56 - $88.17 $4.67 Million - $6.48 Million	-73,478 Reduced 7.96%	849,183 $73 Million
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $3.8 Million - $4.54 Million	-64,918 Reduced 6.57%	922,661 $58.7 Million
Q3 2018 Nov 08, 2018	BUY	$61.75 - $74.23 $5.73 Million - $6.89 Million	92,783 Added 10.37%	987,579 $68.2 Million
Q2 2018 Aug 13, 2018	BUY	$60.85 - $83.98 $37.7 Million - $52 Million	619,591 Added 225.14%	894,796 $60 Million
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $131,317 - $159,649	1,581 Added 0.58%	275,205 $22.9 Million
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $929,518 - $1.16 Million	-9,935 Reduced 3.5%	273,624 $25.9 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $31 Million - $39.2 Million	283,559	283,559 $33.1 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Incyte Corp Transaction History